Título:	Production of gallocyanine nanogel as drug delivery system for tauopathies
Autor(es):	Lunardi, Claure Nain Siqueira, F. S. Leal, F. F. Siqueira, J. W. S. Souza, Igor A. de Gomes, Anderson de Jesus
Data de publicação:	2018
Referência:	Claure Nain Lunardi et al. Production of gallocyanine nanogel as drug delivery system for tauopathies. Journal of Nanomaterials & Molecular Nanotechnology, v. 7, p. 48, 2018. DOI: 10.4172/2324-8777-C3-027.
Abstract:	The aim of this study was to develop and characterize nanogels loaded with gallocyanine dye (GC) for controlled delivery. This dye is as an inhibitor of DKK1-LRP5/6 interactions (Remelli , Zheng and Wu ). Phenoxazines are compounds, present in several bioactive molecules and natural products that display diverse biological activities. Importantly, phenothiazine compounds have also been reported to able to activate the Wnt signaling pathway as indicated by the increased levels of β-catenin, and decrease the DKK1-induced Tau phosphorylation at serine 396 (Thysiadis et al.) The controlled delivery of drugs may be accomplished by employing various polymeric drug carriers such as natural polymers. The great advantage using chitosan polymers are the low cost and biocompatibility ability to entrapments of diverse drugs. The development and characterization of GC-nanogel such as size, zeta potential, drug release in different pH’s and SEM images were obtained for this preparation. GC-nanogel may be a promising vehicle for the drug delivery to inhibit DKK1 in neurodegenerative tauopathies. FAPDF, CNPq, CAPES, FINATEC.
Informações adicionais:	Trabalho apresentado na International Conference on Materials Science & Engineering, Roma, Itália, 25-26 jun. 2018.
DOI:	10.4172/2324-8777-C3-027
Aparece nas coleções:	Artigos publicados em periódicos e afins

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.